TNNI3 and intermediate coronary syndrome: Therefore, cTnI is an ideal cardiomyocyte-specific marker that exhibits high specificity and sensitivity to myocardial damage and has high clinical value in the diagnosis, monitoring, treatment efficacy, observation, and prognosis evaluation of AMI, unstable anginapectoris (UAP), perioperative myocardial injury, and other related diseases.